Abstract
The natural history of glioblastomas has been little altered by therapeutic attempts over the past 30 years. Surgical debulking and radiation therapy have had only a moderate effect on these patients (Neuwelt and Dahlborg 1989), with the median survival being in the range of 7.5–9.5 months (Edwards et al. 1980; Shapiro and Ausman 1969). This dismal prognosis for patients with glioblastomas has stimulated the development of many alternative regimens, such as intra-arterial therapy and local high dose irradiation. This chapter will initially discuss the rationale behind the chemotherapy of brain tumors, the nature of the bloodbrain barrier (BBB) and its significance in the treatment of patients with cerebral glioblastomas, and the problem with the BBB; it will conclude with a discussion on the intra-arterial delivery of chemotherapeutic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baba T, Fukui M, Takeshita I et al. (1990) Selective enhancement of intratumoral blood flow in malignant gliomas using intra-arterial adenosine triphosphate. J Neurosurg 72:907–911
Barranco SC, Humphrey RM (1971) The effects of BCNU on survival and cell progression in Chinese hamster cells. Cancer Res 31:191–195
Bashir R, Hochberg FH, Linggood RM, Hottleman K (1988) Preirradiation internal carotid artery BCNU in treatment of glioblastoma multiforme. J Neurosurg 68:917–919
Black KL, King WA, Ikezaki K (1990) Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg 72:912–916
Charnsangavej C, Lee Y, Carrasco CH et al. (1985) Supraclinoid intracarotid chemotherapy using a flow-directed soft-tipped catheter. Radiology 155:655–657
Clayman DA, Wolpert SM, Heros DO (1989) Super-selective arterial BCNU infusion in the treatment of patients with malignant gliomas. AJNR 10:767–771
DiChiro G, Oldfield E, Wright DC et al. (1987) Cerebral necrosis after radiotherapy and/or intra-arterial chemotherapy for brain tumors: PET and neuropathologic studies. AJNR 8:1083–1091
Doppman JL, Dedrick RL, Shook DR et al. (1986) Glioblastoma: catheter techniques for isolated chemotherapy perfusion. Radiology 159:477–483
Edwards MS, Levin VA, Wilson CB (1980) Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep 64:1179–1205
Fauchon F, Davila L, Chatellier G et al. (1990) Treatment of malignant gliomas with surgery, intra-arterial infusions of l-(2-hydroxyethyl) chloroethylnitrosourea, and radiation therapy: a phase II study. Neurosurgery 27:231–234
Fenstermacher JD, Cowles AL (1977) Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61:519–526
Foo SH, Ransohoff J, Choi IS et al. (1985) Experience with supraophthalmic intra-arterial BCNU infusion in malignant glioma (abstr). Neurology 35 [Suppl]:114
Greenberg HS, Ensminger WD, Seeger JF et al. (1981) Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report. Cancer Treat Rep 65:803–810
Greig NH (1989a) Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In: Neuwelt EA (ed) Implications of the blood-brain barrier barrier barrier and its manipulations. Plenum Medical, New York, pp 311–367
Greig NH (1989b) Brain tumors and the blood-tumor barrier. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 77–106
Groothuis DR, Warkne PC, Molnar P et al. (1990) Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors. J Neurosurg 72:441–449
Hiesiger EM, Voorhies R, Basier GA et al. (1984) Comparison of 14C-methotrexate (14C-MTX) delivery by intravenous vs. intracarotid (IC) route without or with IC mannitol in experimental rat brain tumors as measured by quantitative autoradiography (QAR). Proc Am Assoc Cancer 25:363
Hochberg FH, Pruitt AA, Beck DO et al. (1985) The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma. J Neurosurg 63:876–889
Johnson DW, Parkinson D, Wolpert SM et al. (1987) Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 20: 577–583
Kapp JP, Sanford RA (1986) Neurologic deficit after carotid infusion of cisplatinum and 1-3-bis (2-choroethyl-1-nitrosourea (BCNU) for malignant glioma: An analysis of risk factors. Neurosurgery 19:779–783
Kapp JP, Parker JL, Tucker EM (1985) Supra-ophthalmic carotid infusion for brain chemotherapy. J Neurosurg 62:823–825
Layton PB, Greenberg HS, Stetson PL et al. (1984) BCNU solubility and toxicity in the treatment of maligant astrocytomas. J Neurosurg 60:1134–1137
Lutz RL, Dedrick RL, Boretos JW et al. (1986) Mixing studies during intracarotid infusions in an in vitro model. J Neurosurg 64:277–283
Madajewicz S, West CR, Park HC et al. (1981) Phase II study — intra-arterial BCNU therapy for metastatic brain tumors. Cancer 47:653–657
Mayhein WG, Heistod DD (1985) Permeability of blood-brain barrier to various sized molecules. Am J Physiol 235:H712–H718
Metes JJ, Lazo A, Wilner HI et al. (1985) Supra-ophthalmic placement of microleak balloon catheters for intracranial chemotherapy infusion: complications and results of therapy. AJNR 6:948–952
Nakagawa H, Groothius D, Blasberg RG (1984). The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology 34:1571–1581
Neuwelt EA, Barnett PA (1989) Blood-brain barrier disruption in the treatment of brain tumors: animal studies. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 107–193
Neuwelt EA, Dahlborg SA (1989) Blood-brain barrier disruption in the treatment of brain tumors: clinical implications. In: Neuwelt EA (ed) Implications of the blood-brain barrier and its manipulation. Plenum Medical, New York, pp 195–261
Neuwelt EA, Diehl JD, Vu LH et al. (1981) Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Intern Med 94:449–454
Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA 79:4420–4423
Neuwelt EA, Glasberg M, Frenkel E, Barnett P (1983) Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies. Ann Neurol 14:316–324
Safdari H, Mompeon B, Dubois JB, Gros C (1985) Intraarterial l,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report. Surg Neurol 24:490–497
Saris SC, Blasberg RG, Carson RE et al. (1991) Intravascular streaming during carotid artery infusions: demonstration in humans and reduction using diastolephased, pulsatile administration. J Neurosurg 74:763–772
Saris SC, Shook DR, Blasberg RG et al. (1987) Carotid artery mixing with diastole phased pulsed drug infusion. J Neurosurg 67:721–725
Shapiro WR (1986) Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13(1):38–45
Shapiro WR, Ausman JI (1969) The chemotherapy of brain tumors: a clinical and experimental review. In: Plum F (ed) Recent advances in neurology. FA Davis, Philadelphia, pp 150–235
Shapiro WR, Green SB (1987) Letter to the editor: Reevaluating the efficacy of intra-arterial BCNU. J Neurosurg 66:313–315
Shapiro WR, Shapiro JR (1986) Principles of brain tumor chemotherapy. Semin Oncol 13(1):56–69
Shapiro JR, Yung WK-A, Shapiro WR (1981) Isolation, karyotype and clonal growth of heterogeneous sub-populations of human malignant glioma. Cancer Res 51:2349–2359
Silbergleit R, Steffey DJ, DeFilipp GJ et al. (1989) Cerebral distribution of contrast medium during slow intracarotid infusion. AJNR 10:1061–1064
Wolpert SM, Kwan ESK, Heros D et al. (1988) Selective delivery of chemotherapeutic agents with a new catheter system. Radiology 166:547–549
Yung W-KA, Shapiro WR, Shapiro JR (1982) Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42:992–998
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wolpert, S.M. (1993). Superselective Therapy for Cerebral Gliomas. In: Valavanis, A. (eds) Interventional Neuroradiology. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84434-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-84434-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84436-2
Online ISBN: 978-3-642-84434-8
eBook Packages: Springer Book Archive